CME and CFTC Clash Over On-Chain Perpetual Futures

The US derivatives landscape is witnessing an unusual confrontation between the CME Group, the largest derivatives exchange operator, and its regulator, the Commodity Futures Trading Commission (CFTC), sparked by the agency's decision to allow blockchain-based perpetual futures products. The CME has filed a lawsuit against the CFTC, challenging its decision to permit the listing of crypto perpetual futures by Kalshi and Coinbase, arguing that these products are harmful to its own long-dated futures contracts and that the CFTC has mislabeled them, leading to a misapplication of the law. The CFTC's move has been seen as a significant development in the rapidly growing perps market, with non-US perps volume reportedly reaching $60 trillion in volume last year. The lawsuit has sparked a heated debate, with some voicing frustration and outrage at the CME's stance, while others see it as a necessary step to protect the integrity of the derivatives market. The CME claims that the CFTC's sudden embrace of perpetual futures did not consider the ramifications and that the products are not compliant with existing regulations. The dispute has significant implications for the US approach to the perps market and could have far-reaching consequences for the derivatives industry as a whole. The CFTC's decision to allow perpetual futures has been seen as a move to open up the US market to new products and competitors, but the CME's opposition has raised questions about the regulator's ability to effectively oversee the market. The lawsuit is currently awaiting federal court action, and the outcome is likely to have a significant impact on the future of the perps market in the US.